You are requesting information on: CRISPRCas9-mediated PD-1 Knock-out In Human Primary T Cells Shows Enhanced Cytotoxicity Against Cancer Cells Corning Life Sciences
Already a member of Cell & Gene or VertMarkets? Sign in now.
In order for our suppliers to better serve your request, please enter specific requirements or questions below: